iShares Biotechnology ETF (IBB)'s 30-day implied volatility (IV30) was 25.9% at the close on October 30, 2026, up from 24.7% the day before, against a 52-week range of 16.1% to 30.9%. Its 20-day historical volatility was 28.9%.
Data as of October 30, 2026.